share_log

Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%), etc.

SEC announcement ·  Feb 15 16:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more